Tuesday, November 17, 2026

MUSVI and AMI Collaborate on AI x Remote Audiology to Tackle Remote Island Medical Issues!

AMI and MUSVI, which aim to realize rapid medical innovation through research and development of AI medical devices and social implementation of telemedicine services, announced that they have started collaboration to realize D to P with N-type (Doctor to Patient with Nurse) online medical care.
Through this collaboration, a new telemedicine system will be established by combining AMI's AI-equipped digital stethoscope "Super Stethoscope* (telemedicine support system "Cloud Super Diagnosis®")" and MUSVI's telepresence system "Window" to enable remote listening and cardiac screening by specialists in urban areas even in remote islands and remote areas where there are no specialists available. This new telemedicine system will enable remote audiology and screening for cardiac disease by specialists in urban areas, even in areas where there are no specialists, such as remote islands and remote areas.

Background and Issues

As Japan's population ages, the number of patients with cardiac diseases such as heart failure and valvular heart disease is increasing. On the other hand, there is a growing shortage of cardiologists in rural areas, remote islands, and remote regions, making it difficult to provide appropriate initial diagnosis and prompt screening. As a result, the detection of diseases is delayed, increasing the risk of serious illness and emergency transport, which is a major challenge.

Why is a medical interview and auscultation necessary?

In cardiac disease, changes in heart sounds may appear from the earliest stages of the disease. Skilled auscultation and careful interviewing may detect early the need for lifestyle modification and ambiguous early signs of heart failure and valvular disease.

Furthermore, the results of past efforts are showing that in online medical care, the ability to "interview" and "listen" with clear acoustics, which is comparable to face-to-face, is very important as a base requirement.

In the case of "Q&A," it is difficult to express voice in the same way as in real life using general videoconferencing tools. Specifically, even if the patient's image is projected in front of them, if the timing of the patient's voice is the same as that of the other person's voice when they speak, it causes a great deal of stress for the user, such as the communication of "please repeat that". In addition, it is difficult for doctors to hear the patient's pain and worries.
In this respect, the "interview" with the "window" realizes a natural feeling as if the patient is having a real conversation with the doctor, and for the doctor, a feeling of "being there" and a clear understanding of the patient's voice and facial expression.

Auscultation is an important method of medical examination that is painless and reassuring for patients to have their physical condition carefully checked, and useful for medical professionals to detect abnormal heart and lung sounds at an early stage and determine a diagnosis and treatment plan. It is non-invasive, quick, and can deepen confidence in health care by promptly providing appropriate responses.

solution (esp. to a problem)

The system under this collaboration will realize remote medical care through the following mechanisms

1. medical personnel in the field (remote islands and remote areas) acquire heart sounds and electrocardiographic data with a "super stethoscope" and connect to the "window" through a PC.
2. physicians in urban areas can check the data acquired by the super stethoscope in real time via the content sharing function while interviewing the patient in the "window," which allows for communication equivalent to face-to-face meetings. Instructions for reacquisition can also be given remotely if necessary.
3. acquired data is automatically uploaded to the cloud super diagnostics, and the AI analysis results can be referenced in about 1 to 2 minutes.
4. the physician decides whether or not the patient needs to come to the hospital and whether or not to follow up, based on the analysis results and voice data.

Through this, we aim to create a new telemedicine model in which medical professionals in the field and specialists in urban areas can collaborate to determine cardiac disease risk "on the spot.

Expected Effects

Provides specialist-level screening for cardiac disease in areas where there are no specialists available.
Prevention of serious illness and reduction of medical costs by speeding up initial diagnosis
Reduction of patient burden (reduction of unnecessary long-distance travel and transport)
Correction of medical disparities and promotion of community-based comprehensive care

Future Outlook

Starting with this collaboration, the two companies will promote the deployment of the system not only to remote islands and remote areas, but also to a wide range of sites, including nursing care facilities and home healthcare. Furthermore, with an eye on international expansion, the two companies will contribute to eliminating disparities in access to medical care around the world.

Comment from Mr. Yusuke Sakai, President, Founder & CEO, MUSVI Corporation

By combining "Window," which enables realistic interaction with doctors and medical staff even when they are far away, and AMI's "Super Stethoscope," which aims to assist in rapid and wide-ranging diagnosis from patient heartbeat and electrocardiogram data using AI and other technologies, we will contribute to solving medical issues in remote islands and mountainous areas.

Comments from Mr. Shinpei Ogawa, Representative Director and CEO, AMI, Inc.

This collaboration with MUSVI is a major first step toward the early detection of heart disease and the elimination of regional healthcare disparities. Our goal is to realize a society in which everyone has access to quality medical care wherever they are.

Using this initiative as a starting point, AMI will further advance AI and cloud technologies to take on the challenge of creating a system to deliver medical care to places of daily life such as home healthcare and nursing homes. In the future, we would like to expand our business overseas, where the issue of access to medical care is more serious, and build a system of medical care that provides peace of mind around the world.

AMI is committed to revolutionizing the "accepted practice of medicine" and realizing a sustainable and equitable healthcare infrastructure through the development of innovative medical devices and the implementation of telemedicine services in society.

MUSVI Corporation|Company Profile

name of companyMUSVI Corporation
EstablishmentJanuary 2022
Location5-5-15, Kitashinagawa, Shinagawa-ku, Tokyo
representativeRepresentative Director / Founder & CEO Yusuke Sakai
Business Overview1. Development, planning and operation of the real-space connection platform "MUSVI
2. Sales, leasing and consulting of telepresence system "windows
3.Research and development of telepresence technology and provision of related solutions
uniform resouce locatorHP:https://musvi.jp/
Release:https://musvi.jp/2025/09/30/4925/

AMI Corporation|Company Profile

AMI is an R&D startup from Kyushu, Japan, which is working on "Audiology DX*" through research and development of "Super Stethoscope (telemedicine-compatible stethoscope with cardiac disease diagnosis assist function)". Through product development utilizing acoustic engineering, electronics, and AI technologies, and social implementation of telemedicine services, AMI aims to realize a world in which anyone can receive high-quality medical care anywhere.

We not only digitize auscultation, but also provide new value to the medical field by utilizing it for medical practice, clinical research, medical education, and telemedicine.

This is a promotional video for AMI. Please take a look.

AMI Corporation|Company Profile

name of companyAMI Corporation
EstablishmentNovember 2015
LocationHead Office: 302, 2-13 Higashi Sengoku-cho, Kagoshima City, Kagoshima Prefecture, Japan
Head Office: 5-98 Hamamatsu-cho, Minamata City, Kumamoto Prefecture
representativeShinpei Ogawa, Representative Director and CEO
Business OverviewDevelopment of medical equipment and provision of telemedicine services
uniform resouce locatorhttps://ami.inc/
Contact us for a demo or rental:https://ami.inc/products-service
*Healthcare professionals only

PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。